We are live on ! Find out more
HA

Harfst & Associates Portfolio holdings

AUM $643M
1-Year Est. Return 24.12%
This Fund
S&P 500
This Quarter Est. Return
+1.45%
1 Year Est. Return
+24.12%
3 Year Est. Return
+82.48%
5 Year Est. Return
+108.64%
10 Year Est. Return
+384.36%
AUM
$237M
AUM Growth
-$8.43M
Cap. Flow
-$11.2M
Cap. Flow %
-4.72%
Top 10 Hldgs %
85.6%
Holding
86
New
6
Increased
54
Reduced
14
Closed
5

Top Buys

Rank Stock Value
1
VXF icon
Vanguard Extended Market ETF
VXF
+$1.39M
2
RMD icon
ResMed
RMD
+$463K
3
QQQ icon
Invesco QQQ Trust
QQQ
+$454K
4
UNH icon
UnitedHealth
UNH
+$298K
5
ADSK icon
Autodesk
ADSK
+$215K

Sector Composition

Rank Sector Weight
1 Financials 49.54%
2 Technology 3.72%
3 Consumer Staples 3.7%
4 Industrials 2.9%
5 Healthcare 1.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
26
Mastercard
MA
$500B
$592K 0.25%
3,017
-28
-0.9% -$5.26K
RTN
27
DELISTED
Raytheon Company
RTN
$590K 0.25%
3,057
+4
+0.1% +$840
AMGN icon
28
Amgen
AMGN
$220B
$581K 0.25%
3,151
+144
+5% +$25.5K
COST icon
29
Costco
COST
$418B
$572K 0.24%
2,738
-121
-4% -$23.9K
ROK icon
30
Rockwell Automation
ROK
$50.1B
$567K 0.24%
3,416
+141
+4% +$24.5K
BA icon
31
Boeing
BA
$190B
$566K 0.24%
1,687
+14
+0.8% +$4.82K
COLM icon
32
Columbia Sportswear
COLM
$2.93B
$561K 0.24%
6,141
+22
+0.4% +$1.88K
VFC icon
33
VF Corp
VFC
$5.98B
$517K 0.22%
6,748
+29
+0.4% +$2.19K
SWK icon
34
Stanley Black & Decker
SWK
$15.6B
$506K 0.21%
3,812
+180
+5% +$25.9K
INTC icon
35
Intel
INTC
$510B
$503K 0.21%
10,132
+31
+0.3% +$1.65K
NUS icon
36
Nu Skin
NUS
$253M
$499K 0.21%
6,389
+38
+0.6% +$2.94K
HON icon
37
Honeywell
HON
$78.6B
$496K 0.21%
3,812
+57
+2% +$7.58K
IWF icon
38
iShares Russell 1000 Growth ETF
IWF
$127B
$482K 0.2%
13,420
-1,968
-13% -$69.5K
RHI icon
39
Robert Half
RHI
$4.15B
$474K 0.2%
7,293
+47
+0.6% +$2.98K
RMD icon
40
ResMed
RMD
$32.5B
$474K 0.2%
+4,577
New +$463K
UNP icon
41
Union Pacific
UNP
$176B
$469K 0.2%
3,314
+26
+0.8% +$3.62K
CMI icon
42
Cummins
CMI
$89.7B
$462K 0.2%
3,481
+203
+6% +$30.4K
MDT icon
43
Medtronic
MDT
$110B
$458K 0.19%
5,350
+97
+2% +$8.1K
JNJ icon
44
Johnson & Johnson
JNJ
$621B
$442K 0.19%
3,646
+72
+2% +$8.98K
CVX icon
45
Chevron
CVX
$371B
$440K 0.19%
3,485
+16
+0.5% +$1.99K
TRV icon
46
Travelers Companies
TRV
$79.8B
$428K 0.18%
3,505
+50
+1% +$6.55K
AMTD
47
DELISTED
TD Ameritrade Holding Corp
AMTD
$421K 0.18%
7,698
+83
+1% +$4.94K
APD icon
48
Air Products & Chemicals
APD
$65.7B
$419K 0.18%
2,691
+28
+1% +$4.58K
WST icon
49
West Pharmaceutical
WST
$24.7B
$417K 0.18%
4,207
+75
+2% +$6.9K
HRL icon
50
Hormel Foods
HRL
$13.9B
$416K 0.18%
11,202
+183
+2% +$6.57K

Similar funds

Harfst & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Harfst & Associates held 86 positions worth $237M, down 3.4% from $245M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Harfst & Associates withdrew a net $11.2M in Q2 2018, closing 5 positions and reducing 14 holdings. Its most notable exit was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $1.83M position sold in full.

By sector, the portfolio is most concentrated in Financials at 50% of assets, up from 48% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Harfst & Associates opened a new position in ResMed worth $474K.

  • Harfst & Associates's largest Q2 2018 buy was ResMed: 4,577 shares worth $474K.
  • Harfst & Associates added most to Vanguard Extended Market ETF in Q2 2018, an estimated $1.39M increase.
  • Harfst & Associates's biggest Q2 2018 reduction was Invesco S&P 500 Low Volatility ETF, cutting an estimated $6.65M.
  • Harfst & Associates fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2018, selling an estimated $1.83M.
  • Harfst & Associates's ten largest holdings make up 86% of its $237M portfolio in Q2 2018.
  • Harfst & Associates opened 6 new positions and closed 5 in Q2 2018.
  • Harfst & Associates's portfolio value fell 3.4% quarter-over-quarter to $237M.

Based on Harfst & Associates's 13F filing for Q2 2018, filed 10 Aug 2018.